News & Updates

Individuals who use low-dose aspirin are at risk of developing gastric and duodenal ulcers, especially those who have only recently initiated therapy, a study has found.

Crohn’s disease (CD) remission, induced by either CD exclusion diet with partial enteral nutrition (CDED+PEN) or by exclusive enteral nutrition (EEN), leads to significant changes in metabolite levels in paediatric patients, according to a new study.

The use of a computer-aided detection (CADe) device helps increase the overall rate of adenoma detection during screening and surveillance colonoscopy, reports a new study. Such benefit was apparent even for experienced endoscopists.

Maintenance therapy with the anti-IL-23p19 antibody mirikizumab boosts clinical benefits in moderate-to-severe ulcerative colitis (UC) in the phase III LUCENT-2 trial, improving bowel urgency that is not only disruptive but likewise embarrassing for patients.

Despite no other indication or proven clinical benefit, proton pump inhibitors (PPIs) are frequently inappropriately used to treat lower gastrointestinal bleeding (LGIB), according to a study presented at the recently concluded 2022 Digestive Disease Week (DDW 2022).

Treatment with erlotinib is well tolerated and leads to a reduction in duodenal and lower gastrointestinal polyp burden in patients with familial adenomatous polyposis, according to data from a phase II trial.